An observational study in Socioeconomic Factors, sponsored by Centre Hospitalier de Saint-Denis. Completed at 9 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-31.
Sponsored by Centre Hospitalier de Saint-Denis · Observational
Socioeconomic inequalities are increasingly recognised as an important public health issue, and it is now well established that patients with socioeconomic deprivation (SED) features demonstrate higher mortality and morbidity. The epidemiology and impact of SED on the specific population of ICU patients has been insufficiently investigated.
In this prospective multicenter study of patients admitted to 9 ICUs of the Paris area, the investigators aim to explore the epidemiology of SED features, and its impact on mortality and length of stay.
Centre Hospitalier de Saint-Denis is the lead sponsor of 42 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All consecutive patients admitted to one of the participating ICUs during the study period
Exclusion Criteria:
30-day mortality
30-day mortality
Time frame: 30 days
ICU length of stay
ICU length of stay
Time frame: up to 12 weeks
Hospital length of stay
Hospital length of stay
Time frame: up to 12 weeks
ICU mortality
ICU mortality
Time frame: up to 12 weeks
30-day mortality of pre-specified subgroup of undocumented immigrants
30-day mortality of pre-specified subgroup of patients who are undocumented
Time frame: 30 days
30-day mortality of pre-specified subgroup of deprived patients aged between 18 and 25 years old
30-day mortality of pre-specified subgroup of deprived patients (ie without healthcare coverage and/or without income and/or without housing) aged between 18 and 25 years old
Time frame: 30 days
Plan to share: No
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier de Saint-Denis